Le Lézard
Classified in: Science and technology, Business

Blocknative Introduces Transaction Bundle Send, Cancellation, and Replacement Support in its Block Builder


MEV Searchers can now direct when and where their bundles land on-chain with Blocknative's Builder.

SAN FRANCISCO, Feb. 1, 2023 /PRNewswire-PRWeb/ -- Blocknative introduces transaction bundle send, cancellation, and replacement support for the Blocknative Builder. Searchers can now submit MEV bundles privately to the Blocknative Builder to be included on-chain. This market utility builds upon Blocknative's reliable, real-time infrastructure that is systematically important to the Ethereum ecosystem.

Matt Cutler, CEO & Co-Founder of Blocknative, said, "MEV bundle control is an important element of our block building capabilities. As Ethereum evolves, we remain committed to providing real-time infrastructure that supports transparency, accessibility, and decentralization block by block. To reduce friction and facilitate adoption, we have prioritized ease-of-use by ensuring that our API-level implementation is cross-compatible with the broader builder ecosystem."

Searchers can quickly add the Blocknative Builder to their bundle workflow. The bundle RPC endpoint https://api.blocknative.com/v1/auction uses direct payments instead of gas price to make payments conditional on their transaction succeeding, thus avoiding having to pay for failed bids. With over 269,000 validators connected to the Blocknative Relay via MEV-Boost, searchers can use the Blocknative bundle RPC endpoint to increase their Builder reach and increase the likelihood that their bundles successfully get on-chain.

Searchers can learn more at https://www.blocknative.com/mev-searchers or interact with the RPC endpoint at https://docs.blocknative.com/blocknative-auction/mev-bundle-rpc-endpoint

To engage, join the Blocknative #searcher Discord channel to chat with our dedicated Searcher support team directly.

For media inquiries, please contact Phil LeRoy at (310) 260-7901 or Phil(at)MelrosePR(dot)com

About Blocknative
Blocknative is a leading Ethereum block builder. The company's real-time infrastructure enables validators and searchers to optimize staking rewards and trading profit. Blocknative's end-to-end Transaction Orchestration platform prices, previews, distributes, and monitors events so web3 users can transact with confidence. Blocknative democratizes access to pre-chain data and provides the power to see into the future, improving web3 user experiences and enabling MEV recirculation. Founded in 2018, Blocknative helps inform and power such forward-thinking projects as Lido, MetaMask, imToken, Curve, Balancer, Ethereum Foundation, Polygon Foundation, and hundreds of others. #ShareTheMEV

Media Contact

Phil LeRoy, Melrose PR, 310-260-7901, [email protected]

 

SOURCE Blocknative


These press releases may also interest you

at 14:33
Enabled Intelligence (EI), a global leader in mission-critical AI data solutions for the US Defense and Intelligence Community today announced a groundbreaking new partnership with Melwood, a leading employer, advocate, and service provider for...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
Transflo, a leading provider of technology solutions for the transportation industry, is thrilled to announce that it has won three 2024 Top Workplaces Culture Excellence awards. The honors are awarded by Energage, a purpose-driven organization that...

at 14:05
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today published its 2024 Cyber Claims Report, which details emerging cyber trends and their impact on Coalition policyholders throughout 2023....

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...



News published on and distributed by: